{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:18:00Z","timestamp":1759742280077,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Cancer Research Society (CRS) of Canada"},{"name":"The Collaborative Health Research Projects (CHRP) Program of the Natural Sciences and Engineering Research Council (NSERC) of Canada"},{"name":"Cancer Research Network of the \u201cFonds de la Recherche en Sant\u00e9 du Qu\u00e9bec\u201d (FRSQ), Qu\u00e9bec, Canada"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ygyno.2012.03.026","type":"journal-article","created":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T20:12:18Z","timestamp":1332360738000},"page":"720-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation"],"prefix":"10.1016","volume":"125","author":[{"given":"Kether","family":"Guerrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Bachvarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claude","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Plante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimcho","family":"Bachvarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.03.026_bb0005","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1586\/era.09.167","article-title":"First-line treatment of advanced ovarian cancer: current research and perspectives","volume":"10","author":"Marchetti","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1155\/2007\/474320","article-title":"Etiology and pathogenesis of epithelial ovarian cancer","volume":"23","author":"Mok","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ygyno.2007.12.017","article-title":"DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment","volume":"109","author":"Barton","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0030","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ajog.2004.05.025","article-title":"The epigenetics of ovarian cancer drug resistance and resensitization","volume":"191","author":"Balch","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0035","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1158\/0008-5472.CAN-04-0238","article-title":"DNA hypomethylation and ovarian cancer biology","volume":"64","author":"Widschwendter","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0027-5107(98)00229-2","article-title":"Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential","volume":"423","author":"Qu","year":"1999","journal-title":"Mutat Res"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0045","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1038\/sj.onc.1209145","article-title":"Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors","volume":"25","author":"Ehrlich","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0050","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1158\/1078-0432.CCR-10-2315","article-title":"Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS\/CTCF expression ratio and advanced stage","volume":"17","author":"Woloszynska-Read","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3835(94)90056-6","article-title":"Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis","volume":"79","author":"Simile","year":"1994","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0060","doi-asserted-by":"crossref","first-page":"20812","DOI":"10.1074\/jbc.M211813200","article-title":"The methyl donor S-Adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-Adenosylmethionine","volume":"278","author":"Detich","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0065","doi-asserted-by":"crossref","first-page":"31735","DOI":"10.1074\/jbc.M401669200","article-title":"Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis","volume":"279","author":"Pakneshan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/156800905774574011","article-title":"Hypomethylation of urokinase (uPA) promoter in breast and prostate cancer: prognostic and therapeutic implications","volume":"5","author":"Pakneshan","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0075","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1074\/jbc.R000020200","article-title":"Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes","volume":"276","author":"Hooper","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0925-4439(00)00058-2","article-title":"Ovarian tumor cells express a novel multi-domain cell surface serine protease","volume":"1502","author":"Underwood","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000050604","article-title":"Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention","volume":"22","author":"Tanimoto","year":"2001","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000079146","article-title":"The transmembrane protease serine (TMPRSS3\/TADG-12) D variant: a potential candidate for diagnosis and therapeutic intervention in ovarian cancer","volume":"25","author":"Sawasaki","year":"2004","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2006.03.056","article-title":"Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy","volume":"103","author":"Bignotti","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9440(10)63306-8","article-title":"Differential gene expression in ovarian carcinoma: identification of potential biomarkers","volume":"165","author":"Hibbs","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0105","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/cncr.24048","article-title":"Induction of human tumor-associated differentially expressed gene-12 (TADG-12\/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer","volume":"115","author":"Bellone","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2164-9-99","article-title":"Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids","volume":"9","author":"L'Esperance","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0115","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/jnci\/92.18.1534","article-title":"Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup","volume":"92","author":"Vergote","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ab.2009.07.022","article-title":"Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction","volume":"394","author":"Li","year":"2009","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.molonc.2011.07.003","article-title":"Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer","volume":"5","author":"Mercier","year":"2011","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0130","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/modpathol.2008.80","article-title":"Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas","volume":"21","author":"Tetu","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0135","doi-asserted-by":"crossref","first-page":"e1001356","DOI":"10.1371\/journal.pgen.1001356","article-title":"Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis","volume":"7","author":"Alvarez","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0140","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/art.27363","article-title":"Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells","volume":"62","author":"Li","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0145","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1349-7006.2009.01204.x","article-title":"Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis","volume":"100","author":"Yoshihara","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0150","first-page":"2602","article-title":"A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer","volume":"60","author":"Wallrapp","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0155","first-page":"8614","article-title":"Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies","volume":"63","author":"Iacobuzio-Donahue","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0160","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1158\/1078-0432.CCR-11-0044","article-title":"Global hypomethylation identifies Loci targeted for hypermethylation in head and neck cancer","volume":"17","author":"Poage","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0165","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/1471-2164-11-669","article-title":"Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells","volume":"11","author":"Ke","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ygyno.2012.03.026_bb0170","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/0008-5472.CAN-10-3823","article-title":"Definition of the landscape of promoter DNA hypomethylation in liver cancer","volume":"71","author":"Stefanska","year":"2011","journal-title":"Cancer Res"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581200220X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581200220X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:30:35Z","timestamp":1758771035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581200220X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S009082581200220X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.03.026","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}